• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动脉高血压的治疗方法——最新技术现状。

Therapeutical Approach to Arterial Hypertension - Current State of the Art.

机构信息

Department of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, Belgrade, 11000, Serbia.

Faculty of Medicine, Institute of Pathophysiology "Ljubodrag Buba Mihailović", University of Belgrade, Belgrade, 11000, Serbia.

出版信息

Curr Med Chem. 2024;31(29):4602-4620. doi: 10.2174/0109298673274823231220063652.

DOI:10.2174/0109298673274823231220063652
PMID:38303535
Abstract

Arterial hypertension (AH) is recognized as the most common illness within the group of cardiovascular diseases and the most massive chronic non-infectious disease in the world. The number of hypertensive patients worldwide has reached 1.28 billion, contributing to an increase in cardiovascular diseases and premature death globally. The high prevalence of hypertension emphasizes the importance of effectively treating this condition. Elevated blood pressure often leads to lethal complications (heart failure, stroke, renal disorders, etc.) if left untreated. Considering an increase in AH prevalence in the future, a successful therapeutical approach to this disease and its complications is essential. The goal of AH treatment is to maintain normotensive blood pressure through various approaches, including lifestyle changes, a well-balanced diet, increased physical activity, psychoeducation, and, when necessary, pharmacotherapy. The evolving pharmacotherapeutic landscape reflects the progress made in our understanding of hypertension and emphasizes the need for continuous innovation to meet the challenges posed by this prevalent global health concern. The journey toward more effective and tailored treatments for hypertension is ongoing, and the introduction of new medications plays a pivotal role in shaping the future of antihypertensive pharmacotherapy.

摘要

高血压(AH)被认为是心血管疾病中最常见的疾病,也是世界上最普遍的慢性非传染性疾病。全球高血压患者已达 12.8 亿,导致心血管疾病和全球过早死亡的人数增加。高血压的高患病率强调了有效治疗这种疾病的重要性。如果不进行治疗,血压升高常常会导致致命的并发症(心力衰竭、中风、肾脏疾病等)。考虑到未来 AH 患病率的增加,成功治疗这种疾病及其并发症至关重要。AH 治疗的目标是通过各种方法维持正常血压,包括生活方式改变、均衡饮食、增加身体活动、心理教育以及在必要时进行药物治疗。不断发展的药物治疗领域反映了我们对高血压的理解取得的进展,并强调需要不断创新,以应对这一普遍存在的全球健康问题带来的挑战。朝着更有效和个性化的高血压治疗方法前进的道路仍在继续,引入新的药物在塑造抗高血压药物治疗的未来方面发挥着关键作用。

相似文献

1
Therapeutical Approach to Arterial Hypertension - Current State of the Art.动脉高血压的治疗方法——最新技术现状。
Curr Med Chem. 2024;31(29):4602-4620. doi: 10.2174/0109298673274823231220063652.
2
The future of antihypertensive treatment.抗高血压治疗的未来。
Am J Ther. 2007 Mar-Apr;14(2):121-34. doi: 10.1097/01.pap.0000249915.12185.58.
3
What is resistant arterial hypertension?什么是耐药性动脉高血压?
Blood Press. 2023 Dec;32(1):2185457. doi: 10.1080/08037051.2023.2185457.
4
The Role of Beta-Blockers in the Treatment of Hypertension.β受体阻滞剂在高血压治疗中的作用
Adv Exp Med Biol. 2017;956:149-166. doi: 10.1007/5584_2016_36.
5
Apparent treatment-resistant hypertension associated lifetime cardiovascular risk in a longitudinal national registry.在一个纵向国家注册研究中,与明显的治疗抵抗性高血压相关的终生心血管风险。
Eur J Prev Cardiol. 2023 Aug 1;30(10):960-968. doi: 10.1093/eurjpc/zwad066.
6
[Arterial hypertension in extreme situations].[极端情况下的动脉高血压]
Klin Med (Mosk). 2007;85(10):4-10.
7
Trends in prevalence, awareness, treatment, and control of hypertension, and the risk of mortality among middle-aged Lithuanian urban population in 1983-2009.1983-2009 年立陶宛城市中年人群高血压患病率、知晓率、治疗率和控制率的变化趋势及其死亡率风险。
BMC Cardiovasc Disord. 2012 Aug 31;12:68. doi: 10.1186/1471-2261-12-68.
8
The renin-angiotensin-aldosterone system: a crossroad from arterial hypertension to heart failure.肾素-血管紧张素-醛固酮系统:从动脉高血压到心力衰竭的十字路口。
Heart Fail Rev. 2020 Jan;25(1):31-42. doi: 10.1007/s10741-019-09855-5.
9
Difficult-to-treat hypertensive populations: focus on African-Americans and people with type 2 diabetes.难治性高血压人群:聚焦非裔美国人和2型糖尿病患者。
J Hypertens Suppl. 1999 Feb;17(1):S19-24.
10
Hypertension and Exercise Training: Evidence from Clinical Studies.高血压与运动训练:来自临床研究的证据。
Adv Exp Med Biol. 2017;1000:65-84. doi: 10.1007/978-981-10-4304-8_5.

本文引用的文献

1
The relationship between the systemic immune-inflammation index and reverse-dipper circadian pattern in newly diagnosed hypertensive patients.初诊高血压患者的系统性免疫炎症指数与反杓型昼夜节律模式之间的关系。
J Clin Hypertens (Greenwich). 2023 Aug;25(8):700-707. doi: 10.1111/jch.14688. Epub 2023 Jul 18.
2
The Role of Pharmacogenetics in Personalizing the Antidepressant and Anxiolytic Therapy.《药理学遗传学在个体化抗抑郁和抗焦虑治疗中的作用》。
Genes (Basel). 2023 May 16;14(5):1095. doi: 10.3390/genes14051095.
3
Therapeutic roles of thiazides and loop diuretics in blood pressure control and renal protection against chronic kidney disease.
噻嗪类利尿剂和袢利尿剂在血压控制及预防慢性肾脏病肾脏保护方面的治疗作用。
Clin Hypertens. 2023 May 15;29(1):14. doi: 10.1186/s40885-023-00238-5.
4
Management of hypertensive crisis: British and Irish Hypertension Society Position document.高血压危象管理:英国和爱尔兰高血压学会立场文件。
J Hum Hypertens. 2023 Oct;37(10):863-879. doi: 10.1038/s41371-022-00776-9. Epub 2022 Nov 22.
5
Pharmacokinetics of the most commonly used antihypertensive drugs throughout pregnancy methyldopa, labetalol, and nifedipine: a systematic review.妊娠期最常用的降压药物(甲基多巴、拉贝洛尔和硝苯地平)的药代动力学:系统评价。
Eur J Clin Pharmacol. 2022 Nov;78(11):1763-1776. doi: 10.1007/s00228-022-03382-3. Epub 2022 Sep 15.
6
Angiotensin Receptor Blockers in the Management of Hypertension: A Real-World Perspective and Current Recommendations.血管紧张素受体阻滞剂在高血压治疗中的应用:真实世界的观点和当前建议。
Vasc Health Risk Manag. 2022 Jul 11;18:507-515. doi: 10.2147/VHRM.S337640. eCollection 2022.
7
Efficacy of sacubitril/valsartan versus olmesartan in Japanese patients with essential hypertension: a randomized, double-blind, multicenter study.沙库巴曲缬沙坦对比奥美沙坦治疗日本原发性高血压患者的疗效:一项随机、双盲、多中心研究。
Hypertens Res. 2022 May;45(5):824-833. doi: 10.1038/s41440-021-00819-7. Epub 2022 Jan 21.
8
The importance of healthy lifestyle behaviors in the prevention of cardiovascular disease.健康生活方式行为在心血管疾病预防中的重要性。
Prog Cardiovasc Dis. 2022 Jan-Feb;70:8-15. doi: 10.1016/j.pcad.2021.12.001. Epub 2021 Dec 16.
9
Molecular Immune-Inflammatory Connections between Dietary Fats and Atherosclerotic Cardiovascular Disease: Which Translation into Clinics?膳食脂肪与动脉粥样硬化性心血管疾病之间的分子免疫炎症联系:哪些转化为临床应用?
Nutrients. 2021 Oct 25;13(11):3768. doi: 10.3390/nu13113768.
10
Current concepts and molecular mechanisms in pharmacogenetics of essential hypertension.原发性高血压的药物遗传学的当前概念和分子机制。
Indian J Pharmacol. 2021 Jul-Aug;53(4):301-309. doi: 10.4103/ijp.IJP_593_19.